Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signaling

Wu,Wen; Zhang,Daimin; Pan,Daorong; Zuo,Guangfeng; Ren,Xiaomin; Chen,Shaoliang

doi:10.3892/ijmm.2016.2493

Downregulation of vascular endothelial growth factor receptor-2 under oxidative stress conditions is mediated by β-transduction repeat-containing protein via glycogen synthase kinase-3β signaling

Authors:
- Wen Wu
- Daimin Zhang
- Daorong Pan
- Guangfeng Zuo
- Xiaomin Ren
- Shaoliang Chen
View Affiliations

Affiliations: Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Qinhuai, Nanjing 210006, P.R. China
Published online on: February 18, 2016 https://doi.org/10.3892/ijmm.2016.2493
Pages: 911-920
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular endothelial growth factor receptor-2 (VEGFR-2), which is a key determinant of the angiogenecic response, is decreased in diabetic mice under oxidative stress. β-transduction repeat-containing protein (β-TrCP) has been reported to participate in VEGFR-2 degradation in thyroid cancer cells. Additionally, glycogen synthase kinase-3β (GSK‑3β) acts as a mediator in the β-TrCP-induced degradation of several proteins. However, the role played by β-TrCP and GSK‑3β in the degradation of VEGFR-2 in endothelial cells where hyperglycemia had been induced was not fully understood. In the present study, we aimed to analyze the mechanisms of VEGFR-2 degradation by studying excess reactive oxygen species (ROS) induced by hyperglycemia or glucose oxidase (GO). Human umbilical vein endothelial cells (HUVECs) were treated with different concentrations of glucose (6.6, 19.8 and 33 mM), mannitol (33 mM) and GO (1 U/ml). Angiogenic function, ROS levels, the co-location of VEGFR-2 and β-TrCP were evaluated. Cells were collected for RT-qPCR and western blot analysis. We noted that angiogenesis was impaired upon increasing the glucose concentration. When HUVECs were in a hyperglycemic state, ROS production increased, comparable to exposure to GO; GO catalyzes oxidation of glucose into H2O2 and D-glucono-δ-lactone. Phosphorylated VEGFR-2 was reduced by hyperglycemia while total VEGFR-2 was almost unaltered. However, VEGFR-2 was reduced when directly exposed to ROS, with resultant co-location of β-TrCP and VEGFR-2. Through a co-immunoprecipitation assay, we noted that ubiquitinated VEGFR-2 was significantly augmented by excess ROS. Decreased VEGFR-2 caused by ROS was ameliorated by β-TrCP siRNA, proteasome inhibitor MG132 and GSK‑3β activity inhibitor (lithium chloride and SB216763). We suggest that redundant ROS reduces VEGFR-2 through β-TrCP-mediated VEGFR-2 degradation, which is postulated to be regulated by GSK-3β.

View Figures

View References

1	Waltenberger J: VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. Biochem Soc Trans. 37:1167–1170. 2009. View Article : Google Scholar : PubMed/NCBI
2	Schiekofer S, Galasso G, Sato K, Kraus BJ and Walsh K: Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol. 25:1603–1609. 2005. View Article : Google Scholar : PubMed/NCBI
3	Shibuya M: Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 153:13–19. 2013. View Article : Google Scholar
4	Shibuya M: VEGFR and type-V RTK activation and signaling. Cold Spring Harb Perspect Biol. 5:a0090922013. View Article : Google Scholar : PubMed/NCBI
5	Koch S and Claesson-Welsh L: Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med. 2:a0065022012. View Article : Google Scholar : PubMed/NCBI
6	Shibuya M and Claesson-Welsh L: Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 312:549–560. 2006. View Article : Google Scholar
7	Warren CM, Ziyad S, Briot A, Der A and Iruela-Arispe ML: A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes. Sci Signal. 7:ra12014. View Article : Google Scholar : PubMed/NCBI
8	Chen YS and Qiu XB: Ubiquitin at the crossroad of cell death and survival. Chin J Cancer. 32:640–647. 2013. View Article : Google Scholar : PubMed/NCBI
9	Shaik S, Nucera C, Inuzuka H, Gao D, Garnaas M, Frechette G, Harris L, Wan L, Fukushima H, Husain A, et al: SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2. J Exp Med. 209:1289–1307. 2012. View Article : Google Scholar : PubMed/NCBI
10	Wei S, Lin LF, Yang CC, Wang YC, Chang GD, Chen H and Chen CS: Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma. Mol Pharmacol. 72:725–733. 2007. View Article : Google Scholar : PubMed/NCBI
11	Wei S, Yang HC, Chuang HC, Yang J, Kulp SK, Lu PJ, Lai MD and Chen CS: A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells. J Biol Chem. 283:26759–26770. 2008. View Article : Google Scholar : PubMed/NCBI
12	Cardozo T and Pagano M: The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol. 5:739–751. 2004. View Article : Google Scholar : PubMed/NCBI
13	Li X, Liu J and Gao T: beta-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt. Mol Cell Biol. 29:6192–6205. 2009. View Article : Google Scholar : PubMed/NCBI
14	Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X and He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
15	Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus JU, Weber KJ and Huber PE: Triple combination of irradiation, chemotherapy (pemetrexed), and VEGFR inhibition (SU5416) in human endothelial and tumor cells. Int J Radiat Oncol Biol Phys. 60:1220–1232. 2004. View Article : Google Scholar : PubMed/NCBI
16	Yang BR, Hong SJ, Lee SM, Cong WH, Wan JB, Zhang ZR, Zhang QW, Zhang Y, Wang YT and Lin ZX: Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo. Chin J Integr Med. Dec 22–2014.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
17	Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D and Chakrabarti S: Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Diabetes Res Clin Pract. 65:197–208. 2004. View Article : Google Scholar : PubMed/NCBI
18	Ettenson DS and Gotlieb AI: Centrosomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wounds. Lab Invest. 66:722–733. 1992.PubMed/NCBI
19	Pollman MJ, Naumovski L and Gibbons GH: Endothelial cell apoptosis in capillary network remodeling. J Cell Physiol. 178:359–370. 1999. View Article : Google Scholar : PubMed/NCBI
20	Giacco F and Brownlee M: Oxidative stress and diabetic complications. Circ Res. 107:1058–1070. 2010. View Article : Google Scholar : PubMed/NCBI
21	Choi SE, Jang HJ, Kang Y, Jung JG, Han SJ, Kim HJ, Kim DJ and Lee KW: Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice. Vascul Pharmacol. 53:264–272. 2010. View Article : Google Scholar : PubMed/NCBI
22	Kobayashi T, Matsumoto T and Kamata K: The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models. J Smooth Muscle Res. 41:283–302. 2005. View Article : Google Scholar
23	Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L and Henry RR: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes. 49:263–271. 2000. View Article : Google Scholar : PubMed/NCBI
24	Eldar-Finkelman H and Krebs EG: Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA. 94:9660–9664. 1997. View Article : Google Scholar : PubMed/NCBI
25	Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, et al: Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 7:793–803. 2000. View Article : Google Scholar : PubMed/NCBI
26	Mora A, Sabio G, Risco AM, Cuenda A, Alonso JC, Soler G and Centeno F: Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal. 14:557–562. 2002. View Article : Google Scholar : PubMed/NCBI
27	Klein PS and Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA. 93:8455–8459. 1996. View Article : Google Scholar : PubMed/NCBI
28	Rossetti L: Normalization of insulin sensitivity with lithium in diabetic rats. Diabetes. 38:648–652. 1989. View Article : Google Scholar : PubMed/NCBI
29	Dejana E: The role of wnt signaling in physiological and pathological angiogenesis. Circ Res. 107:943–952. 2010. View Article : Google Scholar : PubMed/NCBI
30	Qi W, Yang C, Dai Z, Che D, Feng J, Mao Y, Cheng R, Wang Z, He X, Zhou T, et al: High levels of pigment epithelium-derived factor in diabetes impair wound healing through suppression of Wnt signaling. Diabetes. 64:1407–1419. 2015. View Article : Google Scholar
31	Hou Q, Lei M, Hu K and Wang M: The effects of high glucose levels on reactive oxygen species-induced apoptosis and involved signaling in human vascular endothelial cells. Cardiovasc Toxicol. 15:140–146. 2015. View Article : Google Scholar
32	Meyer RD, Srinivasan S, Singh AJ, Mahoney JE, Gharahassanlou KR and Rahimi N: PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol Cell Biol. 31:2010–2025. 2011. View Article : Google Scholar : PubMed/NCBI